Analyst Coverage
Bear Stearns
|
Mark Schoenebaum
|
Bernstein Research
|
Geoffrey Porges
|
BDR Research Group
|
Matt Duffy & Matt Jacobson
|
Fortis Bank
|
Geraldine O’Keeffe
|
Goldman Sachs & Company
|
Meg Malloy
|
Jefferies & Co.
|
Adam A. Walsh
|
JP Morgan Chase
|
Geoffrey Meacham
|
Lazard Capital Markets
|
Matthew Osborne
|
Leerink Swann & Co.
|
William Tanner
|
Lehman Brothers Equity Research
|
Jim Birchenough
|
Natexis Bleichroeder
|
Alex To
|
Oppenheimer & Co
|
Brian Abrahams
|
Robert W. Baird
|
Chris J. Raymond
|
Rodman & Renshaw
|
Shaunak Deepak
|
SG Cowen Securities Corp.
|
Phil Nadeau
|
Smith Barney Citigroup
|
Yaron Werber
|
Standard & Poor’s
|
Frank DiLorenzo
|
Stanford Financial Group
|
Biren Amin
|
Thomas Weisel
|
Ian Somaiya
|
Wachovia Capital Markets
|
Aaron Reames
|
William Blair
|
John Sonnier
|
The analysts listed follow Genzyme Corporation. We are providing this list as a service and not as an endorsement or adoption of the information provided by these analysts. Any opinions or estimates regarding the performance of Genzyme made by these analysts are theirs and do not represent the opinions of Genzyme. We are not responsible for information provided in analyst reports, including inaccuracies they may contain. Some of the analysts firms may be market-makers in Genzyme's stock and/or hold other long or short positions in the stock, and may provide services to Genzyme for which they are compensated.
|
|
|
|
CONTACT INFORMATION: |
|
Genzyme Investor Relations
500 Kendall Street
Cambridge, MA 02142
T: 617 252 7500
F: 617 374 7368
Patrick Flanigan – 617 768 6563
Investor Information Line
U.S. T: 800 905 4369
Outside the U.S. T: 678 999 4572
Shareholder Contact
For questions about your shares, replacement of a lost stock certificate or a change of address call our transfer agent.
American Stock Transfer
59 Maiden Lane
New York, NY 10038
T: 212 936 5100
or
Genzyme Shareholder Services
T: 617 768 6686
|
|
|
|
Home
